Highlights Cover Technologies Inc Canadian Securities Exchange

Equities

HAVN

Delayed Canadian Securities Exchange Other stock markets 16:18:21 05/10/2021 BST			5-day change	1st Jan Change
0.45 ^CAD	-13.46%		-26.76%	+52.94%

2023	HAVN Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	CI
2023	HAVN Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HAVN Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	05/04/23	CI
HAVN Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	26/01/23	CI
HAVN Life Sciences Inc. Announces Retail Listing with Loblaws Company Ltd	27/10/22	CI
HAVN Life Sciences Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	27/09/22	CI
HAVN Life Sciences Says Board Putting Together Restructuring Plan	20/09/22	MT
HAVN Life Sciences Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	28/08/22	CI
HAVN Life Sciences Completes First Tranche of Financing Commitment by Alpha Blue Ocean, Reports Warrant Amendments	19/08/22	MT
HAVN Life Sciences Inc. Enters Supply Agreement with MPB Group Inc	28/06/22	CI
HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals	07/06/22	MT
HAVN Life Sciences Inc. Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd	07/06/22	CI
HAVN Life Sciences Inc. Secures Supply Agreement with Atman Retreats	10/05/22	CI
Havn Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia	02/05/22	CI
HAVN Life Sciences Inc. Launches the Brain Evolve Series	13/04/22	CI
HAVN Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	01/04/22	CI
HAVN Life Sciences Inc. Expands Supply Agreement with Mycotopia Therapies Inc	22/03/22	CI
HAVN Life Announces Distribution Deal with Jonluca Enterprises Inc	15/03/22	CI
HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co-op	03/03/22	CI
HAVN Life Sciences Inc.'s Natural Health Products Expects for Introduction to the Australian, New Zealand and Chinese Market in 2022 Through Woke Pharmaceuticals	28/02/22	CI
HAVN Life Sciences Inc. Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research	24/02/22	CI
HAVN Life Sciences Inc. cancelled the acquisition of Spore Life Sciences Inc. from from a group of shareholders.	21/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cover Technologies Inc Canadian Securities Exchange

Equities

HAVN

Highlights

Filters